| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Gerard Zurawski | Q59699408 |
| P2093 | author name string | Ling Ni | |
| Sangkon Oh | |||
| Katherine Upchurch | |||
| Hyemee Joo | |||
| Dorothee Duluc | |||
| Michael Carley | |||
| Muriel Boreham | |||
| Jack Stecher | |||
| Julien Gannevat | |||
| P2860 | cites work | Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis | Q36869958 |
| Antiviral immune responses in the genital tract: clues for vaccines | Q36918159 | ||
| Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting | Q36939901 | ||
| Dendritic cells and B cells maximize mucosal Th1 memory response to herpes simplex virus | Q37019625 | ||
| Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine | Q37067215 | ||
| Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection | Q37106774 | ||
| Dendritic cells and macrophages in the genitourinary tract | Q37197967 | ||
| Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells | Q37221714 | ||
| Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. | Q37225614 | ||
| Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity | Q37280340 | ||
| Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens. | Q37334338 | ||
| HSV-2: in pursuit of a vaccine | Q22306291 | ||
| Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6 | Q24317429 | ||
| Innate immune recognition of viral infection | Q24498364 | ||
| Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity | Q24643886 | ||
| Human dectin-1 deficiency and mucocutaneous fungal infections | Q24645008 | ||
| Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells | Q24653129 | ||
| Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution | Q24679240 | ||
| DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes | Q24682603 | ||
| Dendritic cell-based immunity and vaccination against hepatitis C virus infection | Q26828003 | ||
| Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses | Q27860455 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL | Q28216755 | ||
| Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial | Q28236008 | ||
| The mannose receptor is a pattern recognition receptor involved in host defense | Q28266161 | ||
| A Novel Human Cancer Vaccine Elicits Cellular Responses to the Tumor-Associated Antigen, Human Chorionic Gonadotropin | Q29391980 | ||
| Toll-like receptors: critical proteins linking innate and acquired immunity | Q29615190 | ||
| Dendritic cells: specialized and regulated antigen processing machines | Q29617085 | ||
| Tolerogenic dendritic cells | Q29618755 | ||
| Taking dendritic cells into medicine | Q29619243 | ||
| The nature of the principal type 1 interferon-producing cells in human blood | Q29619763 | ||
| Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo | Q30080006 | ||
| Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine | Q31961522 | ||
| Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production | Q33564666 | ||
| Mucosal immunology of the genital and gastrointestinal tracts and HIV-1 infection | Q33575368 | ||
| Generation of female genital tract antibody responses by local or central (common) mucosal immunization | Q33591251 | ||
| CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells | Q33615124 | ||
| Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue | Q33835473 | ||
| CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. | Q33928441 | ||
| CD1-mediated gamma/delta T cell maturation of dendritic cells | Q33963163 | ||
| Cell biology of antigen processing in vitro and in vivo | Q33985828 | ||
| Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity | Q34025875 | ||
| Phase I randomised clinical trial of an HIV-1(CN54), clade C, trimeric envelope vaccine candidate delivered vaginally | Q34044915 | ||
| Monocyte-mediated defense against microbial pathogens. | Q34065898 | ||
| HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates | Q34085119 | ||
| Antibodies to opacity proteins (Opa) correlate with a reduced risk of gonococcal salpingitis | Q34140979 | ||
| Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR | Q34163004 | ||
| Gimme shelter: the immune system during pregnancy | Q34177939 | ||
| STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis | Q34196284 | ||
| Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells | Q34211233 | ||
| Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells | Q34265522 | ||
| Designing Vaccines Based on Biology of Human Dendritic Cell Subsets | Q34289152 | ||
| Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study | Q34314348 | ||
| Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques | Q34331629 | ||
| Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial | Q34415030 | ||
| Phenotype and function of intestinal dendritic cells | Q34428958 | ||
| NKT cells - conductors of tumor immunity? | Q34547180 | ||
| Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. | Q34573130 | ||
| Mucosal dendritic cells | Q34611254 | ||
| Langerhans cells cross-present antigen derived from skin | Q34650867 | ||
| Humoral immune responses to microbial infections in the genital tract | Q34669747 | ||
| Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate | Q34883543 | ||
| Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells | Q34887778 | ||
| Development of therapeutic HPV vaccines | Q34953499 | ||
| Dendritic cell control of tolerogenic responses | Q34982085 | ||
| Signalling through C-type lectin receptors: shaping immune responses | Q34986405 | ||
| Recent observations on HIV type-1 infection in the genital tract of men and women | Q35071029 | ||
| Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients | Q35116211 | ||
| Epidermal Langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermis. | Q35119724 | ||
| Dendritic Cell Function in Vivo during the Steady State: A Role in Peripheral Tolerance | Q35119879 | ||
| The control of immunity and tolerance by dendritic cell | Q35152256 | ||
| New concepts in immunity to Neisseria gonorrhoeae: innate responses and suppression of adaptive immunity favor the pathogen, not the host | Q35155273 | ||
| Immunology of the human genital tract | Q35160693 | ||
| Dendritic cells in immunity and tolerance-do they display opposite functions? | Q35181775 | ||
| Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses | Q35184456 | ||
| Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women | Q35545581 | ||
| High-risk human papilloma virus infection decreases the frequency of dendritic Langerhans' cells in the human female genital tract | Q45420696 | ||
| Immune responses and protection against vaginal infection after nasal or vaginal immunization with attenuated herpes simplex virus type-2. | Q45745771 | ||
| The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules | Q46385893 | ||
| Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response | Q47757156 | ||
| Cutaneous antigen priming via gene gun leads to skin-selective Th2 immune-inflammatory responses | Q47862092 | ||
| Endometrial epithelial cell responses to coinfecting viral and bacterial pathogens in the genital tract can activate the HIV-1 LTR in an NF{kappa}B-and AP-1-dependent manner. | Q51450449 | ||
| Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody. | Q51475003 | ||
| Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation. | Q51765801 | ||
| Equivalent stimulation of naive and memory CD8 T cells by DNA vaccination: a dendritic cell-dependent process. | Q51959044 | ||
| Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. | Q52041455 | ||
| Targeting antigen to mouse dendritic cells via Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype. | Q53085484 | ||
| Differential capability of human cutaneous dendritic cell subsets to initiate Th17 responses. | Q54034870 | ||
| Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial. | Q54444542 | ||
| Antigen crosspresentation by human plasmacytoid dendritic cells. | Q55044627 | ||
| Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells | Q57134111 | ||
| Migratory Dendritic Cells Transfer Antigen to a Lymph Node-Resident Dendritic Cell Population for Efficient CTL Priming | Q57227729 | ||
| The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells | Q57275938 | ||
| Toll-dependent selection of microbial antigens for presentation by dendritic cells | Q59063722 | ||
| Functional interactions between dendritic cells and NK cells during viral infection | Q60489540 | ||
| Expression and gene transcript of Fc receptors for IgG, HLA class II antigens and Langerhans cells in human cervico-vaginal epithelium | Q67524599 | ||
| Local antibody response to poliovaccine in the human female genital tract | Q69383597 | ||
| Langerhans cells and T lymphocyte subsets in the murine vagina and cervix | Q70138414 | ||
| HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva. The NIAID AIDS Vaccine Clinical Trials Network | Q71932267 | ||
| Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial | Q73329832 | ||
| Opsonic potential, protective capacity, and sequence conservation of the Treponema pallidum subspecies pallidum Tp92 | Q73670485 | ||
| Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium | Q74228757 | ||
| Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle | Q74335025 | ||
| Segregation of B and T cell epitopes of Treponema pallidum repeat protein K to variable and conserved regions during experimental syphilis infection | Q74410125 | ||
| Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation | Q78298259 | ||
| Cutting Edge: Plasmacytoid dendritic cells provide innate immune protection against mucosal viral infection in situ | Q79370164 | ||
| Preferential induction of CD4+ T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1 | Q80057988 | ||
| Antigenic targeting of the human mannose receptor induces tumor immunity | Q80257353 | ||
| Transcutaneous immunization in mice: induction of T-helper and cytotoxic T lymphocyte responses and protection against human papillomavirus-induced tumors | Q80955695 | ||
| Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly(I:C) | Q81235605 | ||
| Human langerhans cells are more efficient than CD14(-)CD1c(+) dermal dendritic cells at priming naive CD4(+) T cells | Q82671265 | ||
| Oral tolerance | Q83849376 | ||
| Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells | Q84569562 | ||
| Dendritic cells as potential targets for mucosal immunotherapy | Q37595311 | ||
| The multifaceted influence of the mucosal microflora on mucosal dendritic cell responses | Q37600188 | ||
| The role of the local microenvironment in regulating susceptibility and immune responses to sexually transmitted viruses in the female genital tract. | Q37621725 | ||
| Dendritic cell subsets in primary and secondary T cell responses at body surfaces | Q37633373 | ||
| Tolerogenic plasmacytoid DC. | Q37683083 | ||
| The CD8+ dendritic cell subset | Q37700814 | ||
| Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. | Q37700833 | ||
| Tolerance and protection against infection in the genital tract. | Q37744918 | ||
| Increased prevalence of sexually transmitted viral infections in women: the role of female sex hormones in regulating susceptibility and immune responses. | Q37836133 | ||
| High-throughput proteomic screening identifies Chlamydia trachomatis antigens that are capable of eliciting T cell and antibody responses that provide protection against vaginal challenge | Q37848686 | ||
| Harnessing dendritic cells for immunotherapy | Q37850082 | ||
| A novel recombinant multisubunit vaccine against Chlamydia | Q37866603 | ||
| An Inclusion Membrane Protein from Chlamydia trachomatis Enters the MHC Class I Pathway and Stimulates a CD8+ T Cell Response | Q37868388 | ||
| DNA immunization with pgp3 gene of Chlamydia trachomatis inhibits the spread of chlamydial infection from the lower to the upper genital tract in C3H/HeN mice | Q37870263 | ||
| Intestinal CD103+ dendritic cells: master regulators of tolerance? | Q37911701 | ||
| Priming of CD8+ and CD4+ T cells in experimental leishmaniasis is initiated by different dendritic cell subtypes | Q38920978 | ||
| A novel Th cell epitope of Candida albicans mediates protection from fungal infection | Q39359695 | ||
| Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity | Q39621141 | ||
| Concomitant activation and antigen uptake via human dectin-1 results in potent antigen-specific CD8+ T cell responses | Q39664739 | ||
| HIV gag protein is efficiently cross-presented when targeted with an antibody towards the DEC-205 receptor in Flt3 ligand-mobilized murine DC. | Q39787210 | ||
| hDectin-1 is involved in uptake and cross-presentation of cellular antigens | Q40094275 | ||
| Human mannose receptor (CD206) in immune response: novel insights into vaccination strategies using a humanized mouse model | Q40179068 | ||
| Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens | Q40327930 | ||
| Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules | Q40587048 | ||
| NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells | Q40618321 | ||
| Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling | Q40748984 | ||
| Mucosal immunity in the female genital tract | Q41682837 | ||
| The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand | Q42012073 | ||
| Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells | Q42012476 | ||
| Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro | Q42022012 | ||
| A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes | Q42039464 | ||
| Organ-dependent in vivo priming of naive CD4+, but not CD8+, T cells by plasmacytoid dendritic cells | Q42767669 | ||
| Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation | Q42861996 | ||
| Quantitative analysis of tpr gene expression in Treponema pallidum isolates: Differences among isolates and correlation with T-cell responsiveness in experimental syphilis | Q42913654 | ||
| Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial | Q42972328 | ||
| The scavenger receptors SRA-1 and SREC-I cooperate with TLR2 in the recognition of the hepatitis C virus non-structural protein 3 by dendritic cells. | Q42995801 | ||
| Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells | Q43120646 | ||
| Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells | Q43647446 | ||
| The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells | Q43891685 | ||
| Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells | Q43999066 | ||
| A controlled trial of a human papillomavirus type 16 vaccine | Q44366335 | ||
| The effect of hormonal contraception on genital tract shedding of HIV-1. | Q44838458 | ||
| CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis. | Q44910134 | ||
| Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans | Q45221904 | ||
| Identification of B- and T-cell epitopes from glycoprotein B of herpes simplex virus 2 and evaluation of their immunogenicity and protection efficacy | Q45362381 | ||
| The role of dendritic cells in immune responses against vaginal infection by herpes simplex virus type 2 | Q35586464 | ||
| Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells | Q35679596 | ||
| Identifying epitopes of HIV-1 that induce protective antibodies | Q35708836 | ||
| Chemokine receptors and leukocyte trafficking in the mucosal immune system. | Q35794672 | ||
| Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. | Q35830147 | ||
| Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects | Q35854117 | ||
| The interface between innate and adaptive immunity | Q35904384 | ||
| Plasmacytoid dendritic cells in immunity | Q35953140 | ||
| Dendritic cells control B cell growth and differentiation | Q35963666 | ||
| Immunologic uniqueness of the genital tract: challenge for vaccine development | Q36099546 | ||
| Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation | Q36118295 | ||
| Glycoprotein G of herpes simplex virus 2 as a novel vaccine antigen for immunity to genital and neurological disease | Q36155337 | ||
| Dendritic cells prime natural killer cells by trans-presenting interleukin 15 | Q36157184 | ||
| Cutaneous dendritic cells | Q36161713 | ||
| Unique features of antiviral immune system of the vaginal mucosa | Q36177229 | ||
| Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity | Q36199422 | ||
| Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses | Q36228375 | ||
| Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine | Q36228405 | ||
| Vaginal epithelial dendritic cells renew from bone marrow precursors | Q36277209 | ||
| Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells | Q36369028 | ||
| Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2 | Q36370493 | ||
| Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node | Q36371218 | ||
| Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance | Q36376611 | ||
| In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination | Q36402359 | ||
| Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells | Q36404025 | ||
| Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance | Q36426325 | ||
| Functional diversity of human vaginal APC subsets in directing T-cell responses | Q36597690 | ||
| Dendritic cells: translating innate to adaptive immunity. | Q36627111 | ||
| Myeloid C-type lectins in innate immunity | Q36655901 | ||
| Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. | Q36858877 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vaccine engineering | Q14861085 |
| dendritic cell | Q506253 | ||
| sexually transmitted infection | Q12198 | ||
| sexual transmission | Q45349134 | ||
| P304 | page(s) | 35-44 | |
| P577 | publication date | 2012-11-29 | |
| P1433 | published in | Microbial Pathogenesis | Q15766470 |
| P1476 | title | Dendritic cells and vaccine design for sexually-transmitted diseases | |
| P478 | volume | 58 |
| Q40067153 | A Herpes Simplex Virus Type 2 Deleted for Glycoprotein D Enables Dendritic Cells to Activate CD4+ and CD8+ T Cells |
| Q39356813 | Anti-apoptotic function of herpes simplex virus -2 latency-associated transcript RL1 sequence and screening of its encoded microRNAs |
| Q37675710 | Dendritic cells from the human female reproductive tract rapidly capture and respond to HIV. |
| Q91830879 | Enhanced delivery of Mycobacterium tuberculosis antigens to antigen presenting cells using RVG peptide |
| Q39538711 | The HPV16 E7 Oncoprotein Disrupts Dendritic Cell Function and Induces the Systemic Expansion of CD11b(+)Gr1(+) Cells in a Transgenic Mouse Model |
| Q34721358 | Transcriptional fingerprints of antigen-presenting cell subsets in the human vaginal mucosa and skin reflect tissue-specific immune microenvironments |
Search more.